炎症小体与中枢神经系统疾病

杜秀明; 张子腾; 宗英; 余琛琳; 张晓冬; 陆国才

doi:10.3969/j.issn.1006-0111.2016.01.004

炎症小体与中枢神经系统疾病

doi: 10.3969/j.issn.1006-0111.2016.01.004

第二军医大学卫生毒理学教研室, 上海 200433

基金项目: "重大新药创制"科技重大专项(2014ZX09J14106);国家自然科学基金(81473291、81402651);上海市自然科学基金(13ZR144940);上海市公共卫生重点实验室建设计划(12GWZX0501)

Inflammasome and diseases of central nervous system

Department of Health Toxicology, Second Military Medical University, Shanghai 200433, China

摘要: 炎症小体是一蛋白复合物,能够识别不同刺激信号,活化后能诱导免疫和炎症应答。NLRP3炎症小体是中枢神经系统中研究最广泛的炎症小体。小胶质细胞、血管周围的巨噬细胞和脑膜巨噬细胞均能表达炎症小体,而炎症小体与急性脑部感染、急性无菌性脑损伤、帕金森病和阿尔茨海默病等的发生发展有密切关系。基于炎症小体与中枢神经系统疾病相关的机制探索和靶向药物开发是目前的研究热点。
- 炎症小体 /
- 中枢神经系统 /
- 小胶质细胞 /
- 巨噬细胞 /
- 帕金森病 /
- 阿尔茨海默病
Abstract: Inflammasome is the body of protein complex which is able to identify different stimulation signals and can induce immune and inflammatory responses when it is activated. NLRP3 inflammasome has been extensively studied in the central nervous system. Microglia, perivascular macrophages and meningeal macrophages express inflammasomes. The occurrence and development of acute brain infection, aseptic acute brain injury, Parkinson disease and Alzheimer disease are closely related to inflammasomes. Based on mechanisms exploration of the inflammasome's role in the central nervous system disorders, its target drug research and development will be greatly addressed in the future.
- inflammasome /
- the central nervous system /
- microglia /
- macrophages /
- Parkinson disease /
- Alzheimer disease

[1]	de Rivero Vaccari JP,Dietrich WD,Keane RW. Activation and regulation of cellular inflammasomes: gaps in our knowledge for central nervous system injury[J]. J Cereb Blood Flow Metab, 2014, 34(3):369-375.
[2]	Heneka MT, Kummer MP, Andrea Stutz, et al. NLRP3 is activated in Alzheimer's disease and contributes to pathology in APP/PS1 mice[J]. Nature, 2013, 493(7434):674-678.
[3]	Weber MD, Frank MG, Tracey KJ, et al. Stress induces the danger-associated molecular pattern HMGB-1 in the hippocampus of male Sprague Dawley rats: a priming stimulus of microglia and the NLRP3 inflammasome[J]. J Neurosci, 2015, 35(1):316-324.
[4]	Ying P, Yang CX, Yu ZQ, et al. Microglial NLRP3 inflammasome activation mediates IL-1β-related inflammation in prefrontal cortex of depressive rats[J]. Brain Behav Immun, 2014, 41:90-100.
[5]	Cribbs DH, Berchtold NC, Perreau V, et al. Extensive innate immune gene activation accompanies brain aging, increasing vulnerability to cognitive decline and neurodegeneration: a microarray study[J]. J Neuroinflammation, 2012, 9:179-196.
[6]	Shao BZ, Wei W, Ke P, et al. Activating cannabinoid receptor 2 alleviates pathogenesis of experimental autoimmune encephalomyelitis via activation of autophagy and Inhibiting NLRP3 inflammasome[J]. CNS Neurosci Ther, 2014, 20(12):1021-1028.
[7]	Weber MD, Frank MG, Tracey KJ, et al. Stress induces the danger-associated molecular pattern HMGB-1 in the hippocampus of male Sprague Dawley rats: a priming stimulus of microglia and the NLRP3 inflammasome[J]. J Neurosci, 2015, 35:316-324.
[8]	Walsh JG,Muruve DA,Paver C.Inflammasomes in the CNS[J].Nat Rev Neurosci,2014,15(2):84-97.
[9]	Kumar M, Roe K,Orillo B, et al. Inflammasome adaptor protein apoptosis-associated speck-like protein containing CARD (ASC) is critical for the immune response and survival in West Nile virus encephalitis[J]. Virol, 2013, 87:3655-3667.
[10]	Hoegen T, Tremel N,, et al. The NLRP3 inflammasome contributes to brain injury in pneumococcal meningitis and is activated through ATP-dependent lysosomal cathepsin B release[J]. J Immunol, 2011, 187:5440-5451.
[11]	Pradillo JM, Denes A, Greenhalgh AD, et al. Delayed administration of interleukin-1 receptor antagonist reduces ischemic brain damage and inflammation in comorbid rats[J]. J Cereb Blood Flow Metab, 2012, 32:1810-1819.
[12]	Lupfer C, Kanneganti TD. Unsolved Mysteries in NLR Biology[J]. Front Immunol, 2013, 4:285-294.
[13]	Richter K, Kiefer KP, Grzesik BA, et al. Hydrostatic pressure activates ATP-sensitive K⁺ channels in lung epithelium by ATP release through pannexin and connexin hemichannels[J]. FASEB J, 2014, 28(1):45-55.
[14]	Kampen JMV, Baranowski D, Kay DG. Progranulin gene delivery protects dopaminergic neurons in a mouse model of Parkinson's disease[J]. PLoS One, 2014, 9(5):e97032.
[15]	Codolo G, Plotegher N, Pozzobon T, et al. Triggering of inflammasome by aggregated α-synuclein, an inflammatory response in synucleinopathies[J]. PLoS One,2013,8(1):e55375.
[16]	Lu M, Sun XL, Qiao C, et al. Uncoupling protein 2 deficiency aggravates astrocytic endoplasmic reticulum stress and nod-like receptor protein 3 inflammasome activation[J]. Neurobiology Aging, 2014, 35:421-430.
[17]	Guillot-Sestier MV, Town T. Innate immunity in Alzheimer's disease: a complex affair[J]. CNS Neurol Disord Drug Targets, 2013, 12:593-607.
[18]	Halle A,Hornung V,Petzold GC,et al. The NALP3 inflammassome is involved in the innate immune reponse to amyloid-beta[J].Nat Immunol,2008,9(8):857-865.
[19]	Tan Ms,Yu JT,Jiang T,et al.The NLRP3 inflammasome in Alzheimer's disease[J].Mol Neurobiol,2013,84(3):875-82.

[1]	何晓莉, 施艺玮, 王辉, 戴建英, 洪战英. 细胞代谢组学及其在中枢神经系统疾病研究的应用进展 . 药学实践与服务, 2023, 41(2): 63-69. doi: 10.12206/j.issn.2097-2024.202203006
[2]	豆甲泰, 刘友昊, 梁启超, 吴宜艳. 血红铆钉菇多糖对RAW264.7巨噬细胞免疫调节作用研究 . 药学实践与服务, 2021, 39(5): 449-453. doi: 10.12206/j.issn.1006-0111.202102005
[3]	华荣, 陈瑶. 益母草碱抑制NLRP3炎症小体过度激活调控巨噬细胞M1/M2表型分化 . 药学实践与服务, 2021, 39(2): 143-147. doi: 10.12206/j.issn.1006-0111.202101003
[4]	沈越, 张静静, 杜晶, 曹奇, 刘冲, 钱皎. α7n型乙酰胆碱能受体在小胶质细胞中下调炎症水平的作用及其机制研究 . 药学实践与服务, 2021, 39(4): 340-344, 358. doi: 10.12206/j.issn.1006-0111.202103028
[5]	张文杰, 孙迪阳, 王培. 炎症小体介导的细胞焦亡在非酒精性脂肪肝病中的作用及机制 . 药学实践与服务, 2020, 38(1): 9-13,41. doi: 10.3969/j.issn.1006-0111.201902051
[6]	林张军, 李倩, 章越凡, 芮耀诚. 巨噬源性泡沫细胞中p62蛋白上调作用和机制的研究 . 药学实践与服务, 2019, 37(5): 400-405,426. doi: 10.3969/j.issn.1006-0111.2019.05.004
[7]	底雪梅, 袁曜晖, 张超, 高越. 黄芪甲苷抑制U937巨噬细胞CCL18表达及其作用机制研究 . 药学实践与服务, 2019, 37(1): 32-36,41. doi: 10.3969/j.issn.1006-0111.2019.01.008
[8]	万素馨, 向毅, 罗亚玲. 多奈哌齐联合美金刚治疗阿尔茨海默病的有效性及安全性系统评价 . 药学实践与服务, 2018, 36(3): 260-264,281. doi: 10.3969/j.issn.1006-0111.2018.03.015
[9]	徐玲, 赵岩, 茆玲, 张习红. 早期肠道菌群干预对帕金森病患者便秘症状及多巴丝肼疗效的影响 . 药学实践与服务, 2018, 36(6): 547-550. doi: 10.3969/j.issn.1006-0111.2018.06.015
[10]	徐栋丽, 应茵, 陆绪亮, 宋洪涛, 戴海斌. 1例帕金森病伴部分精神障碍患者的用药分析和药学监护 . 药学实践与服务, 2017, 35(5): 460-462,465. doi: 10.3969/j.issn.1006-0111.2017.05.019
[11]	王彦, 俞仲望, 陈思, 李玲, 朱臻宇. 气相色谱-质谱联用结合代谢组学方法研究不同极化状态下小胶质细胞的代谢差异 . 药学实践与服务, 2015, 33(3): 226-230. doi: 10.3969/j.issn.1006-0111.2015.03.009
[12]	赵婷, 沈甫明. NALP3炎性复合体在阿尔茨海默病中的作用 . 药学实践与服务, 2011, 29(2): 81-82,88.
[13]	王婧, 肖振宇, 邱磊, 张俊平. 商陆皂苷甲作用于子宫内膜异位症大鼠腹腔巨噬细胞蛋白质组的差异分析 . 药学实践与服务, 2010, 28(6): 410-413,450.
[14]	闫明俞, 陈虹. 不同脑区注射6-羟基多巴胺制备帕金森病动物模型的方法 . 药学实践与服务, 2009, 27(1): 1-3.
[15]	王逢春, 张瑞麟. 三萜皂苷的中枢神经系统作用 . 药学实践与服务, 2007, (3): 140-142.
[16]	刘晔, 齐荔红, 章越凡, 肖振宇, 张珉, 张俊平. 6种黄酮化合物对大鼠肝星状细胞胶原合成的抑制作用 . 药学实践与服务, 2006, (2): 83-86.
[17]	齐荔红, 刘晔, 肖振宇, 王硕丰, 张珉, 张俊平. 4种黄酮化合物对小鼠腹腔巨噬细胞纤维化因子产生及作用的影响 . 药学实践与服务, 2006, (5): 264-267.
[18]	庄东平, 王硕丰, 章越凡, 桂敏, 张珉, 张俊平. 水飞蓟宾对小鼠腹腔巨噬细胞释放纤维化因子的影响 . 药学实践与服务, 2006, (1): 20-22.
[19]	刘晔, 齐荔红, 王硕丰, 章越凡, 桂敏, 张珉, 张俊平. 肝星状细胞HSC-T6体外肝纤维化模型的建立 . 药学实践与服务, 2005, (6): 339-342.
[20]	任吉霞, 邱贞琴. 脂肪乳注射液致中枢神经系统不良反应1例 . 药学实践与服务, 2001, (1): 43-43.

点击查看大图

计量

文章访问数: 2991
HTML全文浏览量: 277
PDF下载量: 130
被引次数: 0

姓名
邮箱
手机号码
标题
留言内容
验证码

留言板

炎症小体与中枢神经系统疾病

doi: 10.3969/j.issn.1006-0111.2016.01.004

Inflammasome and diseases of central nervous system

计量

炎症小体与中枢神经系统疾病

doi: 10.3969/j.issn.1006-0111.2016.01.004

第二军医大学卫生毒理学教研室, 上海 200433

English Abstract

Inflammasome and diseases of central nervous system

Department of Health Toxicology, Second Military Medical University, Shanghai 200433, China

全文HTML

目录

留言板

炎症小体与中枢神经系统疾病

doi: 10.3969/j.issn.1006-0111.2016.01.004

Inflammasome and diseases of central nervous system

计量

出版历程

炎症小体与中枢神经系统疾病

doi: 10.3969/j.issn.1006-0111.2016.01.004

第二军医大学卫生毒理学教研室, 上海 200433

English Abstract

Inflammasome and diseases of central nervous system

Department of Health Toxicology, Second Military Medical University, Shanghai 200433, China

全文HTML

目录